Study at a glance
What question did the studies ask?
How does the vitamin D receptor bring other proteins into the process of changing gene activity? Five experimental studies examined different parts of this question, using prepared proteins, laboratory cells and an altered mouse receptor.
What did they find?
Active vitamin D helped the receptor recruit partner proteins in the tested systems. DNA, the receptor’s partner and the kind of protein being recruited changed the result. A small change in the receptor could behave differently from removing part of it or removing the receptor completely.
What does this mean?
Finding the receptor, or seeing another protein attached to it, does not tell us the whole response. Researchers also need to test whether gene activity changes and what happens in the relevant cells or tissues.
What are the limits?
These are mainly molecular experiments, not trials of vitamin D3 supplements in people. They do not establish a personal dose, a universal sequence of protein recruitment or a health benefit from increasing one partner protein.
Read the full article below ↓The vitamin D receptor can connect a chemical signal with changes in gene activity, but that connection requires more than the receptor simply being present. This review compares five primary studies of receptor activation, co-regulator recruitment and the functional consequences of altering the recruitment machinery. The experiments help distinguish physical association from transcriptional activity, explain why DNA and receptor partners matter, and show why different receptor defects cannot be treated as equivalent. For a shorter overview of the same evidence, see Vitamin D Receptor Activation and Co-Regulator Recruitment: Study Summary.
| Study | Main experimental contribution | Limit of that contribution |
|---|---|---|
| Rachez 1998 | Removing and restoring a recruited protein fraction tested its contribution to cell-free transcription. | Extracts and reporter templates do not reproduce every native cell. |
| Zhang 2011 | DNA and receptor-partner conditions altered distant coactivator-facing surfaces. | Protein dynamics and reporter responses do not identify every direct atomic contact. |
| Belorusova 2020 | A larger MED1 fragment contacted a broader receptor assembly than a short motif alone. | The reconstructed complex was not complete Mediator in an intact tissue. |
| Sánchez-Martínez 2006 | Combined receptor ligands restored selected responses of a VDR point mutant. | A point mutation is different from deleting the activation surface. |
| Doms 2024 | An activation-surface deletion impaired tested activation while retaining corepressor interactions. | An altered receptor differs from receptor absence; the exact physiological mediator remains uncertain. |
The receptor is one part of a transcriptional system
Calcitriol, also called 1,25-dihydroxyvitamin D, is the active vitamin D hormone used in many receptor experiments. It differs from cholecalciferol, the vitamin D3 supplied in ordinary supplements, and from the circulating precursor 25-hydroxyvitamin D. Directly adding calcitriol to a laboratory preparation bypasses several steps that determine exposure in a living person. A molecular response to that addition therefore cannot, on its own, predict the effect of taking vitamin D3. The wider receptor family is introduced in Vitamin D and Nuclear Receptors, while Vitamin D Receptors explains the receptor itself.
The vitamin D receptor, abbreviated VDR, belongs to the nuclear-receptor family. It commonly works with the retinoid X receptor, or RXR, and can bind selected regulatory DNA sequences. Co-regulators are additional proteins that influence how this assembly affects transcription, the production of RNA messages from genes. Coactivators can support activation in a tested setting; corepressors can support repression. These functional names do not mean that adding more of a protein always moves every gene in one direction.
An activation surface near the end of VDR, commonly called AF2 and involving helix 12, helps the receptor interact with selected co-regulators. The important question is not simply whether that surface exists. Its conformation, the partner receptor, the DNA and the particular co-regulator can affect the observed interaction. Experiments using a short recognition motif, a larger protein fragment and an entire cellular preparation consequently answer related but different questions.
Four claims should remain separate throughout the comparison: a ligand binds the receptor; a partner associates with it; transcription changes; and a physiological outcome follows. A result at one level can motivate a test at the next. It does not automatically complete the chain. This distinction is especially important when a visually convincing protein structure is used to explain a much broader tissue response. Foundational intracellular binding experiments are reviewed in Cellular Signalling Mechanisms of Active Vitamin D: Full Evidence Review.
Making recruitment a functional experiment
Rachez and colleagues in 1998 isolated a ligand-dependent receptor-interacting protein fraction, called DRIP, using a VDR ligand-binding fragment and human B-cell nuclear extracts. Their experiments connected recruitment to transcription: depletion reduced activity in a cell-free reporter system, and adding the fraction back restored or enhanced the tested response. This goes beyond observing that two proteins occur together. The removed material was functionally relevant under those assay conditions. In the tested receptor constructs, ligand-dependent recruitment also depended on the AF2 activation surface, linking the recruitment mechanism with the depletion-and-addback transcriptional result. Individual activation-surface substitutions did not have identical effects, so this is not a claim that every AF2 mutation abolishes binding.
The same paper provides an important contrary result. High expression of DRIP100 could suppress a cellular reporter response, an effect described as squelching. A simple “more cofactor means more activation” interpretation therefore fails within the original evidence. Competition for components or changes in their balance are possible explanations for an overexpression result; the observation does not establish a universal physiological effect of DRIP100 abundance.
The preparation contained multiple components, and the receptor and DNA reporter were simplified experimental materials. The findings do not prove that one component is indispensable in every cell. Nor does activity associated with the mixed preparation establish that purified Mediator itself has an intrinsic histone-acetylating function. The useful conclusion is narrower: ligand-associated recruitment and a functional transcriptional contribution were connected experimentally, while the composition and assay setting limit how far that result can be transferred.
DNA can influence the recruitment surface
Zhang and colleagues in 2011 examined intact VDR and RXR proteins together with DNA and a receptor-interacting fragment of the coactivator SRC1. Hydrogen: deuterium exchange measurements tracked changes in how protected different protein regions were. DNA binding and DNA sequence altered regions distant from the DNA-binding site. Partner liganding and coactivator-motif changes also affected the system, with cellular reporter experiments supplying a functional comparison.
This supports communication between parts of the assembly, often termed allostery. Information does not need to travel only from ligand binding towards DNA. The DNA-bound state can also influence surfaces involved in recruiting a partner. Thus a result obtained with an isolated ligand-binding domain cannot be assumed to describe an intact receptor pair on every regulatory sequence.
Protection in an exchange experiment can reflect altered shape or movement as well as a direct contact. It is not an atomic map of every interaction. The SRC1 material was a fragment, and the reporters were engineered systems. Some figure and text labels also differ, so precise disputed reporter fold changes are not needed for the conclusion here. The defensible contribution is the context dependence of the assembled receptor’s surfaces and response, rather than one numerical rule for all DNA sequences.
A larger MED1 fragment reveals a broader interface
Belorusova and colleagues in 2020 reconstructed a DNA-bound VDR/RXR complex with an extended fragment of MED1, a component of the Mediator transcriptional machinery. The fragment included more than a short receptor-binding motif. Several biophysical approaches supported one MED1 fragment associating with the receptor heterodimer and revealed dynamic interactions across a broader interface than that described by the short motif alone.
VDR helix 12 was required for the tested MED1 association. In contrast, disrupting RXR’s conventional AF2 interaction surface did not prevent binding in this preparation. That does not make RXR irrelevant: other RXR surfaces contributed to, or were affected by, the extended interaction. The finding distinguishes the role of a particular canonical docking surface from the role of the partner protein as a whole.
This larger-fragment approach improves the comparison with short peptides, but it still does not contain complete MED1, whole Mediator and native cellular chromatin. Some measured protection changes may be indirect conformational effects. The combined structural and dynamic data should not be described as a complete atomic structure of the entire transcriptional machine. The study establishes a more extensive assembly mechanism in its reconstructed system, rather than an organ-level consequence or a universal MED1 requirement at every VDR-responsive gene. The separate chromatin question is examined in Vitamin D, Chromatin Accessibility and Epigenetic Marks: Full Evidence Review.
A point mutation and a deletion are different tests
Sánchez-Martínez and colleagues in 2006 provide a necessary qualification to a simple inactive-AF2 model. In engineered cell and protein assays, combined calcitriol and an RXR ligand restored selected transcriptional responses of the VDR E420Q point mutant, including a reporter and an endogenous CYP24A1 response. A point mutation changes a particular position; it leaves much of the surrounding receptor structure present.
The paper also examined helix-12 deletions in recruitment experiments. Those are not the same intervention as the point mutant used for the restored transcriptional responses. It would therefore be incorrect to say that these results show an RXR ligand generally restores a deleted activation surface. Equally, the experiment prevents describing RXR as universally silent or every activation-surface mutation as having one fixed outcome.
The comparison with the MED1 study depends on the exact reagents and questions. Short coactivator-interaction fragments, extended MED1 and cellular transcription assays are not interchangeable readouts. The result is a mechanistic qualification, not evidence for treating a receptor disorder with a combination of vitamins or retinoids. No clinical rescue was tested, and the interpretation here does not rely on unseen supplementary results.
A present but recruitment-defective receptor can retain activity
Doms and colleagues in 2024 compared an AF2-deficient VDR with normal receptor and receptor absence. Removing the receptor’s final 12 amino acids impaired the tested ligand-dependent coactivator-peptide interactions and classical reporter activation. Corepressor interactions remained detectable. A tendency towards stronger interaction with one corepressor, NCOR1, should not be expanded into statistically established enhancement of every repressive interaction.
The mouse comparison also showed that the altered receptor and a receptor-null state had different mineral and skeletal consequences. That difference is relevant here because it demonstrates why “activation impaired” cannot simply be substituted for “receptor absent.” The detailed systemic outcomes require their own evidence comparison; they do not identify a particular co-regulator-bound gene as the sole cause of the phenotype.
The biochemical tests used selected peptides and reporters, and the main animal comparison involved a developmental mutation in young female mice. Those conditions limit transfer to normal human physiology. Deleting an activation surface may alter more than one interaction. “Coactivator-independent” also does not mean that every remaining response is ligand-independent. The study supplies a functional distinction between lost activation and retained receptor functions, not a general map of all repression in every tissue.
What the comparisons establish together
The studies support a receptor assembly whose behaviour depends on its components and context. The early depletion-and-addback work tests a functional contribution of recruited material. The intact-receptor and extended-MED1 work tests how DNA and protein surfaces participate in assembly. Mutant and deletion comparisons test what is lost and what can remain. These are complementary lines of evidence, not repetitions of one identical experiment with a shared effect size.
This is why a universal recruitment sequence would overstate the evidence. A plausible diagram can show ligand, receptor, DNA and a co-regulator, but the arrows need experimental meanings. Does an arrow represent direct physical proximity, altered protein movement, a change in reporter activity, or a measured tissue effect? Labelling those meanings prevents the diagram from silently upgrading association into necessity or a molecular response into physiological benefit.
Experimental removal and restoration also need careful language. Removing a component can test whether a response depends on it in the tested system. Adding it back can strengthen that attribution. Restoring a receptor in a deficient organism asks whether that restoration is sufficient to correct particular outcomes under those conditions. None of these designs, by its name alone, proves that every intermediate molecular event has been isolated.
The general roles of transcription factors and gene expression therefore remain distinct from this recruitment question. A co-regulator interaction may help explain how a response becomes possible, while other experiments are needed to identify which genes respond in a particular cell, how quickly their RNA changes and whether the corresponding protein or function follows. Broader regulatory-network, chromatin and systemic comparisons supply those additional questions without turning this molecular review into a claim about every vitamin D action. For these different layers, see Vitamin D and Transcription Factors and Vitamin D and Gene Expression.
How much weight should the mechanism carry?
Direct manipulation makes these experiments more informative for their molecular questions than receptor detection alone. However, experimental control and biological completeness are different strengths. A purified preparation makes it easier to interpret a defined interaction, while removing the surrounding cellular machinery. A cellular reporter restores some complexity, while simplifying the regulatory DNA and expression conditions. A mouse perturbation adds physiological integration, together with developmental and endocrine consequences that complicate assignment to one molecular step. The downstream physiological comparisons are assessed in Vitamin D, Gene Regulation and Physiological Outcomes: Full Evidence Review.
The five publications represent distinct experimental studies, although several belong to connected traditions of receptor research. Reusing an earlier reagent, citing a previous structure or performing several assays does not produce another independent study. The value of the set lies in the different questions tested and the limitations exposed, rather than a vote count in favour of a beneficial effect.
A practical reading of receptor evidence therefore asks which ligand was used, which receptor and co-regulator material was present, what was manipulated and what was measured. It also asks whether the claimed outcome is recruitment, transcription or physiology. Keeping those distinctions visible supports a detailed account of nuclear-receptor signalling while leaving personal supplement decisions outside what these experiments establish.
Sources
Related reading
Association between vitamin D serum levels and adolescent idiopathic scoliosis
The results were compared to a second group composed of healthy individuals.
Original paper ↗Read more →Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Original paper ↗Read more →Immunological maladaptation preceding spontaneous preterm birth in human pregnancies
The majority of spontaneous preterm births (sPTB) occurs without identifiable clinical indications or apparent risk factors.
Original paper ↗Read more →Maternal and neonatal vitamin D status, genotype and childhood celiac disease
We therefore aimed to test whether low maternal and neonatal 25-hydroxyvitamin D predicted higher risk of childhood celiac disease.
Original paper ↗Read more →Prognostic role of vitamin D receptor in digestive system tumours: A systematic review and preliminary meta-analysis
The prognostic value of vitamin D receptor (VDR) in a variety of digestive system tumours remains controversial.
Original paper ↗Read more →Reengineering Endogenous Targeting Lipid Nanoparticles (ENDO) for Systemic Delivery of mRNA to Pancreas
Lipid nanoparticles (LNPs) hold transformative potential for nucleic acid delivery, with applications ranging from clinical use, particularly in COVID‐19 vaccines, to gene therapy and cancer immunotherapy.
Original paper ↗Read more →Vitamin D status and associated factors among HIV-infected children and adolescents on antiretroviral therapy in Kampala, Uganda
We aimed to determine the vitamin D status of HIV infected children and factors associated with suboptimal vitamin D.
Original paper ↗Read more →Vitamin D Receptor Activation and Co-Regulator Recruitment: Study Summary
A plain-English summary of five studies on vitamin D receptor partners, gene activity and why different receptor defects can produce different responses.
Read more →Vitamin D Receptor Activation Influences NADPH Oxidase (NOX2) Activity and Protects against Neurological Deficits and Apoptosis in a Rat Model of Traumatic Brain Injury
In the present study, rats were randomly assigned to the sham, TBI, and calcitriol-treated groups.
Original paper ↗Read more →Vitamin D Receptor Activation Mitigates the Impact of Uremia on Endothelial Function in the 5/6 Nephrectomized Rats
Endothelial dysfunction increases cardiovascular disease risk in chronic kidney disease (CKD).
Original paper ↗Read more →Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease: a randomized trial
Thirty-six patients with moderate CKD were randomized to 12 weeks treatment with placebo, 1 μg, or 2 μg paricalcitol daily.
Original paper ↗Read more →Effects of human interleukins in the transgenic gene reporter cell lines IZ-VDRE and IZ-CYP24 designed to assess the transcriptional activity of vitamin D receptor
The role of vitamin D receptor (VDR) in immune responses has been broadly studied and it has been shown that activated VDR alters the levels of some interleukins (ILs).
Original paper ↗Read more →Transcriptional activity of vitamin D receptor in human periodontal ligament cells is diminished under inflammatory conditions
The aim of this study is to investigate possible alterations of the vitamin D3 activity in hPDLCs under inflammatory conditions.
Original paper ↗Read more →Tissue and Organ Expression of the Vitamin D Receptor: Full Study
Detailed review of vitamin D receptor distribution across tissues and organs.
Read more →Intestinal VDR, Barrier Function and Microbial Metabolism: Full Evidence Review
Examine vitamin D receptor experiments on intestinal barriers and microbial metabolism, alongside human trials of permeability, immune markers and microbiota.
Read more →Vitamin D Receptor Inhibits NLRP3 Activation by Impeding Its BRCC3-Mediated Deubiquitination
The NLRP3 inflammasome is a multiprotein oligomer responsible for activation of the inflammatory response by promoting the maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18.
Original paper ↗Read more →Functional Consequences of Tissue-Specific Vitamin D Signalling: Full Study
In-depth analysis of functional outcomes associated with tissue-specific vitamin D signalling.
Read more →Calcitriol restrains microglial M1 polarization and alleviates dopaminergic degeneration in hemiparkinsonian mice by boosting regulatory T‐cell expansion
In this study, we investigated the therapeutic effects of vitamin D receptor activation by calcitriol on PD, specifically focusing on its role in Treg.
Original paper ↗Read more →Immunohistochemical detection of the 1,25-dihydroxy vitamin D receptor in the human vagina
Vitamin D plays a critical role in the regulation of growth and differentiation of squamous epithelium.
Original paper ↗Read more →The Therapeutic Effect of Active Vitamin D Supplementation in Preventing the Progression of Diabetic Nephropathy in a Diabetic Mouse Model
Diabetic nephropathy (DN) is one of the most common microvascular complications of diabetes and is the leading cause of end-stage renal disease (ESRD) and replacement therapy worldwide.
Original paper ↗Read more →Vitamin D Receptor Sensitivity and Density
Vitamin D receptor sensitivity and density help explain why vitamin D responses vary between individuals.
Read more →Original sources
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system
Published in Rachez C, Suldan Z, Ward J, et al. Genes & development (1998).
Publication details
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Rachez C, Suldan Z, Ward J, et al. Genes & development. 1998;12(12):1787. DOI: 10.1101/gad.12.12.1787.
DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex
Published in Zhang J, Chalmers MJ, Stayrook KR, et al. Nature structural & molecular biology (2011).
Publication details
DNA binding alters coactivator interaction surfaces of the intact VDR-RXR complex. Zhang J, Chalmers MJ, Stayrook KR, et al. Nature structural & molecular biology. 2011;18(5):556. DOI: 10.1038/nsmb.2046.
Molecular determinants of MED1 interaction with the DNA bound VDR-RXR heterodimer
Published in Belorusova AY, Bourguet M, Hessmann S, et al. Nucleic acids research (2020).
Publication details
Molecular determinants of MED1 interaction with the DNA bound VDR-RXR heterodimer. Belorusova AY, Bourguet M, Hessmann S, et al. Nucleic acids research. 2020;48(19):11199. DOI: 10.1093/nar/gkaa775.
The retinoid X receptor ligand restores defective signalling by the vitamin D receptor
Published in Sánchez-Martínez R, Castillo AI, Steinmeyer A, et al. EMBO reports (2006).
Publication details
The retinoid X receptor ligand restores defective signalling by the vitamin D receptor. Sánchez-Martínez R, Castillo AI, Steinmeyer A, et al. EMBO reports. 2006;7(10):1030. DOI: 10.1038/sj.embor.7400776.
Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose
The vitamin D receptor (VDR) plays a critical role in the regulation of mineral and bone homeostasis.
Publication details
Coactivator-independent vitamin D receptor signaling causes severe rickets in mice, that is not prevented by a diet high in calcium, phosphate, and lactose. Doms S, Verlinden L, Janssens I, et al. Bone research. 2024;12(1):44. DOI: 10.1038/s41413-024-00343-7.